Postextrasystolic potentiation echocardiography in predicting reversible myocardial dysfunction by surgical coronary revascularization

Sustained inotropic stimulation, such as dobutamine infusion, has the potential to cause an additional contractile deterioration in viable but chronically hypoperfused and dysfunctioning myocardium, by inducing ischemia. Postextrasystolic potentiation (PESP) represents a potent inotropic stimulus wi...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 81; no. 12; pp. 36G - 40G
Main Authors Scognamiglio, Roldano, Marin, Marco, Miorelli, Manuela, Palisi, Monica, Fasoli, Giuseppe, Dalla Volta, Sergio
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 18.06.1998
Elsevier
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Sustained inotropic stimulation, such as dobutamine infusion, has the potential to cause an additional contractile deterioration in viable but chronically hypoperfused and dysfunctioning myocardium, by inducing ischemia. Postextrasystolic potentiation (PESP) represents a potent inotropic stimulus without risk of provoking ischemia, as it is instantaneous. In this study, we assessed the role of PESP-echocardiographic examination in predicting the recovery of regional contractility after coronary revascularization. We examined 105 consecutive patients with multivessel coronary artery disease who were candidates for bypass surgery; 79 were included in this prospective study. Preoperative reversibility of contractile dysfunction in asynergic myocardial regions was determined by PESP, with a coupling interval of 500 msec decreasing to 300 msec, with a progressive decrease by 10 msec. The examination was accompanied by continuous 2-dimensional (2D) echocardiographic monitoring. The assessed sensitivity and specificity were 92% and 87%, respectively; the predictive accuracy was 90%. These results demonstrated that PESP echocardiography is a useful and cost-effective method for identifying viable myocardium in patients undergoing myocardial revascularization.
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(98)00052-6